These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33141415)

  • 21. Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs.
    Varma N; Hu Y; Connolly AT; Thibault B; Singh B; Mont L; Nabutovsky Y; Zareba W
    Heart Rhythm; 2021 Sep; 18(9):1577-1585. PubMed ID: 33965608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exploration of the association between ischemic etiology and the likelihood of heart failure hospitalization following cardiac resynchronization therapy.
    Powell AC; Rogstad TL; Deshmukh UU; Price SE; Simmons JD
    Clin Cardiol; 2017 Nov; 40(11):1090-1094. PubMed ID: 28846805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
    Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
    J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
    Martens P; Deferm S; Bertrand PB; Verbrugge FH; Ramaekers J; Verhaert D; Dupont M; Vandervoort PM; Mullens W
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):895-906. PubMed ID: 31326478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy is associated with improvement in clinical outcomes in Indian heart failure patients: Results of a large, long-term observational study.
    Naik A; Singh B; Yadav R; Pandurangi U; Kler TS; Shankar B; Radhakrishnan R; Rajan V; Bhatia V; Kaul U; Varma J; Dora S; Narasimhan C
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S377-S383. PubMed ID: 30595293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
    Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
    Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    Oki T; Ishii S; Takigami Y; Eda Y; Maemura K; Yazaki M; Fujita T; Ikeda Y; Nabeta T; Maekawa E; Koitabashi T; Ako J
    J Cardiol; 2022 Mar; 79(3):358-364. PubMed ID: 34756767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).
    Kutyifa V; Naqvi SY; Brown M; McNitt S; Goldenberg I; Klein H; Moss AJ
    Am J Cardiol; 2018 Jun; 121(12):1567-1574. PubMed ID: 29625702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.
    Lund LH; Braunschweig F; Benson L; Ståhlberg M; Dahlström U; Linde C
    Eur J Heart Fail; 2017 Oct; 19(10):1270-1279. PubMed ID: 28176416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Goldenberg I; Moss AJ; Rao M; McNitt S; Huang DT; Zareba W; Barsheshet A
    Heart Rhythm; 2012 Sep; 9(9):1454-9. PubMed ID: 22521920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
    Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.